Tumor response as important parameter during first-line treatment of metastatic colorectal carcinoma (mCRC) with panitumumab plus FOLFIRI

M Karthaus, R Hofheinz, L Mineur, H Letocha, Richard Greil, J Thaler, E Fernebro, Y Zhang, G Demonty, CH Kohne

Research output: Contribution to journalAbstract (Journal)peer-review

Original languageEnglish
Pages (from-to)73-73
JournalOncology Research and Treatment
Volume39
Publication statusPublished - 2016

Cite this